ResMed (RMD) Director Peter C. Farrell Sells 970 Shares

What Happened Peter C. Farrell, a director of ResMed Inc. (RMD), disposed of 970 shares on September 2, 2026 at $234.73 per share, generating proceeds of $227,688. The sale was reported on a Form 4 filed September 4, 2026. This was a sale (not a purchase); sales by insiders are often routine and do not necessarily indicate changed expectations about the company.

Key Details

• Transaction date: 2026-09-02; Price: $234.73 per share; Shares sold: 970; Total proceeds: $227,688.
• Method: Reported as an open-market or private sale (code S).
• Footnote: Transaction conducted under a Rule 10b5-1 plan adopted August 12, 2025.
• Filing: Form 4 filed 2026-09-04 — appears timely (filed two days after the trade).
• Shares owned after transaction: Not specified in the provided filing excerpt.

Context A Rule 10b5-1 plan is a pre-arranged trading plan that lets insiders sell shares on a set schedule or under predetermined conditions; trades under such plans are generally considered pre-planned and reduce the likelihood the sale reflects non-public, company-specific information. For retail investors, purchases typically carry more bullish signal value than routine sales; this single sale should be interpreted as a routine insider disposition unless combined with other significant insider activity.